Loading the company…
Loading the company…
Families: Debridement & negative-pressure wound therapy, Hernia repair.
All companies · Product and company coverage
In the last ten years FDA made 11 decisions for Kci (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2019 (5). The latest was on 2024-05-23.
| Family | Decisions on record |
|---|---|
| Debridement & negative-pressure wound therapy | 27 |
| Hernia repair | 1 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2024-05-23 | 510(k) | K241134 | 3M ActiV.A.C. Canister - 300ml with Gel (M8275058/5, M8275058/10) |
| 2020-07-08 | 510(k) | K201571 | ACTIV.A.C. Negative Pressure Wound Therapy System |
| 2020-05-18 | 510(k) | K200390 | V.A.C. DERMATAC Drape |
| 2019-11-22 | 510(k) | K190697 | PREVENA PLUS Incision Management System (No Ag); PREVENA PLUS DUO Incision Management System (No Ag) |
| 2019-04-19 | De Novo |
| DEN180013 |
| PREVENA 125 and PREVENA PLUS 125 Therapy Units |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Kci.